Exercise augments the effect of sglt2 inhibitor dapagliflozin on experimentally induced diabetic cardiomyopathy, possible underlying mechanisms

HIGHLIGHTS

• who: Mamdouh Eldesoqui and collaborators from the Department of Anatomy, Faculty of Medicine, Mansoura University, Mansoura, EgyptTabuk, Saudi Arabia have published the research work: Exercise Augments the Effect of SGLT2 Inhibitor Dapagliflozin on Experimentally Induced Diabetic Cardiomyopathy, Possible Underlying Mechanisms, in the Journal: Metabolites 2022, 12, x FOR PEER REVIEW of /2022/
• what: This study aims to investigate the protective effect of sodium-glucose transport 2 (SGLT2i) and/or exercise DCM. The authors adopted SGLT2 inhibitors as they were superior to other hypoglycemic drugs in cardiovascular complications , and the authors used dapagliflozin as it is . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.